SCHEMBL4294666

SCHEMBL4294666

CO[C@H]1O[C@H](COC(=O)c2ccccc2)[C@@H](OC)[C@H](OC(=O)c2ccccc2)[C@H]1OC(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 11/20 0.52
▸ USP2 O75604 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ F11 P03951 2/20 0.47
▸ TMPRSS2 O15393 1/20 0.47
▸ PDE5A O76074 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ HMGCR P04035 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ LCK P06239 1/20 0.47
▸ FYN P06241 1/20 0.47
▸ HSPD1 P10809 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CA6 P23280 1/20 0.47
▸ TBXAS1 P24557 1/20 0.47
▸ MAPK3 P27361 1/20 0.47
▸ MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1521371 1.00 PTPN1 (0.52) PTPN1USP2MEN1POLBKMT2A
SCHEMBL18068236 0.96 PTPN1 (0.56) PTPN1USP2MEN1POLBKMT2A
SCHEMBL22455860 0.96 PTPN1 (0.56) PTPN1USP2MEN1POLBKMT2A
SCHEMBL17850298 0.96 PTPN1 (0.56) PTPN1USP2MEN1POLBKMT2A
SCHEMBL14428922 0.96 PTPN1 (0.56) PTPN1USP2MEN1POLBKMT2A
SCHEMBL13250762 0.96 PTPN1 (0.56) PTPN1USP2MEN1POLBKMT2A
SCHEMBL14405192 0.96 PTPN1 (0.56) PTPN1USP2MEN1POLBKMT2A
SCHEMBL20730007 0.96 PTPN1 (0.56) PTPN1USP2MEN1POLBKMT2A
SCHEMBL13271795 0.96 PTPN1 (0.56) PTPN1USP2MEN1POLBKMT2A
SCHEMBL13250766 0.96 PTPN1 (0.56) PTPN1USP2MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 — — US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 — — EP disclosed
WO-1993017032-A1 TECHNIQUES AND INTERMEDIATES FOR PREPARING NON-PEPTIDE PEPTIDOMIMETICS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1993-09-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 PTPN1 1591/4885USP2 4135/4885MEN1 3776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback